| Current Price | $9.20 | Mkt Cap | $233.7M |
|---|---|---|---|
| Open | $9.25 | P/E Ratio | 0.00 |
| Prev. Close | $9.20 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $9.00 - $9.45 | Volume | 137,925 |
| 52-Wk Range | $4.67 - $15.12 | Avg. Daily Vol. | 486,432 |
| Current Price | $9.20 | Mkt Cap | $233.7M |
|---|---|---|---|
| Open | $9.25 | P/E Ratio | 0.00 |
| Prev. Close | $9.20 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $9.00 - $9.45 | Volume | 137,925 |
| 52-Wk Range | $4.67 - $15.12 | Avg. Daily Vol. | 486,432 |
The best Bull and Bear pitches based on recency and number of recommendations.
Speculative play. 0.85 is a hard resistance, if breaks out, could see 1.3-1.5 in 6 months
Stage 3 cancer drug research is not living up to promises.
Read the most recent pitches from players about ATNM.
Recs
genedom
(89.11)
Submitted: 10/18/2018 2:36:37 PM :
Start Price:
$0.73
NYSE MKT:ATNM Score:
+1,114.48
Speculative play. 0.85 is a hard resistance, if breaks out, could see 1.3-1.5 in 6 months
Recs
wisnasty60
(< 20)
Submitted: 7/16/2016 12:08:08 PM :
Start Price:
$1.69
NYSE MKT:ATNM Score:
+362.70
Company with potential breakthrough treatment for older patients with leukemia. Drugs in Phase 2 & 3 trials at the moment.
Recs
fireonice1970
(< 20)
Submitted: 1/28/2015 6:01:48 PM :
Start Price:
$5.76
NYSE MKT:ATNM Score:
+36.48
Stage 3 cancer drug research is not living up to promises.
Find the members with the highest scoring picks in ATNM.
DeathStock (78.60) Score: +1,199.81
The Score Leader is the player with the highest score across all their picks in ATNM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| DeathStock | 78.60 | 7/31/2017 |
|
5Y | $0.68 | +1,258.74% | +58.93% | +1,199.81 | 0 Comment | |
| Momentum21 | 72.35 | 10/4/2017 |
|
5Y | $0.70 | +1,223.74% | +55.43% | +1,168.31 | 0 Comment | |
| NateVDM214 | < 20 | 6/21/2018 |
|
3M | $0.71 | +1,195.77% | +42.46% | +1,153.31 | 0 Comment | |
| zzlangerhans | 99.74 | 10/24/2017 |
|
1Y | $0.72 | +1,177.78% | +53.21% | +1,124.57 | 0 Comment | |
| genedom | 89.11 | 10/18/2018 |
|
1Y | $0.73 | +1,156.83% | +42.35% | +1,114.48 | 1 Comment | |
| jck444 | 73.99 | 7/18/2017 |
|
5Y | $1.06 | +767.92% | +60.43% | +707.50 | 0 Comment | |
| ptbradford | 23.69 | 11/17/2016 |
|
5Y | $1.06 | +769.24% | +79.78% | +689.46 | 0 Comment | |
| wisnasty60 | < 20 | 7/18/2016 |
|
3Y | $1.69 | +444.89% | +82.19% | +362.70 | 1 Comment | |
| YacineNYC | < 20 | 9/26/2016 |
|
5Y | $1.90 | +384.21% | +83.47% | +300.74 | 0 Comment | |
| PorscheG96 | 86.19 | 3/10/2016 |
|
3Y | $2.00 | +360.00% | +96.61% | +263.39 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
